PMID- 15880701 OWN - NLM STAT- MEDLINE DCOM- 20051004 LR - 20161124 IS - 1542-0752 (Print) IS - 1542-0752 (Linking) VI - 73 IP - 6 DP - 2005 Jun TI - Effects of epidermal growth factor (EGF), transforming growth factor-alpha (TGFalpha), and 2,3,7,8-tetrachlorodibenzo-p-dioxin on fusion of embryonic palates in serum-free organ culture using wild-type, EGF knockout, and TGFalpha knockout mouse strains. PG - 447-54 AB - BACKGROUND: 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is teratogenic in mice, producing cleft palate (CP). TCDD exposure disrupts expression of epidermal growth factor (EGF) receptor, EGF, and transforming growth factor-alpha (TGFalpha) in the palate and affects proliferation and differentiation of medial epithelial cells. EGF knockout embryos are less susceptible to the induction of CP by TCDD. This study used palate organ culture to examine the hypothesis that EGF enables a response to TCDD. METHODS: The midfacial tissues from wild-type (WT), EGF knockout, C57BL/6J, and TGFalpha knockout embryos were placed in organ culture on gestational day (GD) 12. Palatal explants were cultured for 4 days in serum-free Bigger's (BGJ) medium with 0.1% dimethyl sulfoxide (DMSO) or 1 x 10(-8) M TCDD with or without 2 ng of EGF/ml, 1 or 2 ng of TGFalpha/ml. Effects on palatal fusion were evaluated on day 4 of culture. EGF levels in explants and medium were determined using Luminex technology. RESULTS: In serum-free, control medium, palates from all of the strains fused. EGF knockout palates cultured with TCDD (no EGF) fused, but those cultured with TCDD + 2 ng of EGF/ml failed to fuse (p < 0.05 vs. control or TCDD without EGF). TGFalpha knockout palates failed to fuse when cultured with TCDD + 2 ng of TGFalpha/ml. EGF levels increased in tissue and accumulated in the medium after 24 hr of culture. CONCLUSIONS: This study demonstrated that providing EGF to the palates of EGF knockout mice restored the response to TCDD. These studies support the hypothesis that the mechanism for induction of CP by TCDD is mediated via the EGFR pathway. CI - (c) 2005 Wiley-Liss, Inc. FAU - Abbott, Barbara D AU - Abbott BD AD - Reproductive Toxicology Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA. Abbott.barbara@epa.gov FAU - Buckalew, Angela R AU - Buckalew AR FAU - Leffler, Korin E AU - Leffler KE LA - eng PT - Journal Article PT - Research Support, U.S. Gov't, Non-P.H.S. PL - United States TA - Birth Defects Res A Clin Mol Teratol JT - Birth defects research. Part A, Clinical and molecular teratology JID - 101155107 RN - 0 (Culture Media, Serum-Free) RN - 0 (Polychlorinated Dibenzodioxins) RN - 0 (Transforming Growth Factor alpha) RN - 62229-50-9 (Epidermal Growth Factor) SB - IM MH - Animals MH - Culture Media, Serum-Free MH - Epidermal Growth Factor/genetics/*pharmacology/physiology MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Organ Culture Techniques MH - Polychlorinated Dibenzodioxins/*pharmacology MH - Transforming Growth Factor alpha/genetics/*pharmacology/physiology EDAT- 2005/05/10 09:00 MHDA- 2005/10/05 09:00 CRDT- 2005/05/10 09:00 PHST- 2005/05/10 09:00 [pubmed] PHST- 2005/10/05 09:00 [medline] PHST- 2005/05/10 09:00 [entrez] AID - 10.1002/bdra.20133 [doi] PST - ppublish SO - Birth Defects Res A Clin Mol Teratol. 2005 Jun;73(6):447-54. doi: 10.1002/bdra.20133.